Kaess BM, Pedley A, Massaro JM, Murabito J, Hoffmann U, Fox CS
In such a study (16-week randomized, double-blind, placebo-controlled), 204 individuals with obesity but not diabetes were treated with self-administered subcutaneous injections of pramlintide (nonforced dose escalation 240 g) or placebo three times a day, 15 minutes before meals without concomitant lifestyle intervention (200)
Delivery method: Injectable (subcutaneous), oral capsules, or oral spray
Explore our complete range of research peptides and compounds, and pair your bacteriostatic water with compounds like CJC-1295/Ipamorelin, BPC-157, or NAD+ 500mg to build a complete research protocol
Subject to offer terms Our #1 wrinkle relaxer for a smooth, youthful look
doi: 10.1016/j.ebiom.2021.103242 94 XiaZDickensMRaingeaudJDavisRJGreenbergME